Market cap
$16.487 B
$590.67 +0.97%
Close of 7 Aug 2026
Revenue
$2.53B
#1015 by revenue
Earnings
$451.1M
#657 by earnings
Shares outstanding
27,911,655
Latest filing cover page
P/E ratio
36.5
Cap ÷ net income
Biotechnology: Commercial Physical & Biological Resarch — ranked by market cap
All 12 →Where these numbers come from
Share counts and financials for Medpace are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.